The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaintel Regulatory News (MAI)

Share Price Information for Maintel (MAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 240.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 20.00 (8.333%)
Open: 250.00
High: 250.00
Low: 250.00
Prev. Close: 250.00
MAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 and Results Update

30 Mar 2020 07:00

RNS Number : 9450H
Maintel Holdings PLC
30 March 2020
 

Maintel Holdings Plc

COVID-19 and Results Update

 

Maintel Holdings plc (the "Group" or "Maintel") today issues the following update in light of the rapidly changing developments regarding COVID-19 and the timetable for the publication of its audited financial results for the year ended 31 December 2019 ("2019 Full Year Results"). 

The Company reports that trading for the first quarter of the financial year ended 31 December 2020 is in line with expectations. It has seen an increase in demand for cloud services in this period, but is now starting to see customers putting certain projects on hold and delaying placing orders in response to COVID-19.

The unknown duration and extent of the macro and micro economic consequences of the pandemic makes predicting future near term demand for the Company's offering difficult at this stage. However, it is worth noting that approximately 70% of the Company's revenue for the last financial year was recurring, providing a base level of visibility for revenues in the current period. We continue to monitor the situation closely as it develops and will update investors further when we announce our 2019 Full Year Results.

Enabling organisations to facilitate flexible and remote co-working with business continuity support and delivery is a core competency for Maintel and we are engaged in many projects with clients in both public and private sectors, helping them to keep critical services running through this period.

Owing to recent unprecedented events, the release of the audited 2019 Full Year Results will be delayed. A further announcement will be made as appropriate regarding the expected release date.

The 2019 Full Year Results are expected to be in line with the trading update published by the Company in January 2020, with revenue of approximately £123m and adjusted EBITDA of approximately £10.8m excluding IFRS 16 adjustments and approximately £11.7m including IFRS 16 adjustments.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014

 

For further information please contact:

 

 

Ioan MacRae, Chief Executive Officer

Mark Townsend, Chief Financial Officer

0344 871 1122

Rufus Grig, Chief Strategy Officer

 

 

finnCap (Nomad and Broker)

 

Jonny Franklin-Adams / Kate Bannatyne (Corporate Finance)

Richard Chambers / Sunila de Silva (Corporate Broking)

 

020 7220 0500

Oakley Advisory (Financial Advisors)

Christian Maher / Victoria Boxall

 

 

020 7766 6900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFZGZFNNKGGZM
Date   Source Headline
3rd Feb 20213:00 pmRNSGrant of Options
25th Jan 20217:00 amRNSTrading Update
22nd Jan 202112:49 pmRNSRule 2.8 Announcement
21st Jan 202111:00 amRNSPrice Monitoring Extension
11th Jan 20214:47 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSDirector Dealing
11th Dec 20204:19 pmRNSBoard Changes
25th Nov 20204:41 pmRNSSecond Price Monitoring Extn
25th Nov 20204:36 pmRNSPrice Monitoring Extension
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:01 pmRNSPrice Monitoring Extension
18th Sep 20207:00 amRNSGrant & Exercise of Options & Total Voting Rights
15th Sep 20207:00 amRNSInterim Results
11th Sep 20209:00 amRNSDirector Appointment
3rd Sep 20204:49 pmRNSDirector/PDMR Shareholding
10th Aug 20207:00 amRNSDirector/PDMR Shareholding
6th Jul 20205:14 pmRNSDirector Dealings
1st Jul 20205:05 pmRNSDirector/PDMR Shareholding & Total Voting Rights
30th Jun 20204:28 pmRNSBoard Changes
30th Jun 20204:10 pmRNSResult of AGM
5th Jun 20202:51 pmRNSHolding(s) in Company
5th Jun 20207:41 amRNSHolding(s) in Company
4th Jun 20204:01 pmRNSDirector Shareholding and Total Voting Rights
4th Jun 202012:26 pmRNSPosting of Annual Report and Accounts
1st Jun 20205:18 pmRNSDirector/PDMR Shareholding
1st Jun 20207:00 amRNSFinal Results
30th Apr 20204:46 pmRNSDirector/PDMR Shareholding
6th Apr 20207:00 amRNSHolding(s) in Company
1st Apr 20204:22 pmRNSDirector/PDMR Shareholding
1st Apr 20201:52 pmRNSHolding(s) in Company
30th Mar 20207:00 amRNSHolding(s) in Company
30th Mar 20207:00 amRNSCOVID-19 and Results Update
2nd Mar 20202:58 pmRNSDirector/PDMR Shareholding
21st Feb 20204:15 pmRNSGrant of Options
5th Feb 20203:00 pmRNSDirector/PDMR Shareholding
24th Jan 202011:00 amRNSHolding(s) in Company
22nd Jan 20204:20 pmRNSHolding(s) in Company
17th Jan 202010:28 amRNSHolding(s) in Company
15th Jan 20205:31 pmRNSHolding(s) in Company
10th Jan 20204:53 pmRNSHolding(s) in Company
9th Jan 20207:00 amRNSTrading Statement
2nd Jan 20204:10 pmRNSNotification of Transactions of Directors/PDMR
2nd Dec 20195:00 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSDirector/PDMR Shareholding
16th Oct 20197:00 amRNSGrant of Options
11th Oct 20194:35 pmRNSDirector/PDMR Shareholding
9th Oct 20194:43 pmRNSDirector/PDMR Shareholding
4th Oct 20197:00 amRNSBoard Update
3rd Oct 20192:30 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.